Association of cardio-ankle vascular index with brain natriuretic peptide levels in hypertension

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 3, 2012, Pages 255-262

  Masugata, Hisashi ^a   Senda, Shoichi ^a   Inukai, Michio ^a   Murao, Koji ^a   Himoto, Takashi ^a   Hosomi, Naohisa ^b   Murakami, Kazushi ^a   Noma, Takahisa ^a   Kohno, Masakazu ^a   Okada, Hiroki ^a   Goda, Fuminori ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cardio ankle vascular index; Echocardiography; Hypertension; Plasma brain natriuteric peptide

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; ASCENDING AORTA; BLOOD VESSEL PARAMETERS; BRAIN NATRIURETIC PEPTIDE BLOOD LEVEL; CARDIO ANKLE VASCULAR INDEX; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART SIZE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANKLE; ANKLE BRACHIAL INDEX; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; VASCULAR RESISTANCE;

EID: 84859097830     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.10314     Document Type: Article

References (36)

1. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med, 1998; 339: 321-328
2. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall-Pedoe H, McMurray JJ, Dargie HJ: Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998; 351: 9-13
3. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, Levy D: Plasma natriuretic peptides for com- munity screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA, 2002; 288: 1252-1259
4. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med, 2004; 350: 655-663
5. Eguchi K, Matsui Y, Shibasaki S, Ishikawa J, Hoshide S, Ishikawa S, Kabutoya T, Schwartz JE, Pickering TG, Shimada K, Kario K; Japanese Morning Surge Study Group: Changes in self-monitored pulse pressure correlate with improvements in B-type natriuretic Peptide and urinary albumin in treated hypertensive patients. Am J Hypertens, 2007; 20: 1268-1275
6. Tanaka Y, Daida H, Imai Y, Miyauchi K, Sato Y, Hiwatari M, Kitagawa A, Kishimoto J, Yamazaki T, Kawamori R: Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1. Hypertens Res, 2009; 32: 770-774
7. Andreadis EA, Georgiopoulos DX, Tzavara CK, Katsanou PM, Fragouli EG, Mavrokefalou EM, Chatzis NA, Ifanti GK, Diamantopoulos EJ: Plasma brain natriuretic peptide: a biochemical marker of effective blood pressure management? J Hypertens, 2009; 27: 425-432
8. Ito H, Ishii K, Iwakura K, Nakamura F, Nagano T, Takiuchi S: Impact of azelnidipine treatment on left ventricular diastolic performance in patients with hypertension and mild diastolic dysfunction: multi-center study with echocardiography. Hypertens Res, 2009; 32: 895-900
9. Shirai K, Utino J, Otsuka K, Takata M: A novel blood pressure-independent arterial wall stiffness parameter; Cardio Ankle Vascular Index (CAVI). J Atheroscler Thromb, 2006; 13: 101-107
10. Ibata J, Sasaki H, Kakimoto T, Matsuno S, Nakatani M, Kobayashi M, Tatsumi K, Nakano Y, Wakasaki H, Furuta H, Nishi M, Nanjo K: Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pract, 2008; 80: 265-270
11. Okura T, Watanabe S, Kurata M, Manabe S, Koresawa M, Irita J, Enomoto D, Miyoshi K, Fukuoka T, Higaki J: Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res, 2007; 30: 335-340
12. Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H: Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J, 2008; 72: 598-604
13. Nakamura K, Iizuka T, Takahashi M, Shimizu K, Mikamo H, Nakagami T, Suzuki M, Hirano K, Sugiyama Y, Tomaru T, Miyashita Y, Shirai K, Noike H: Association between cardio-ankle vascular index and serum cystatin C levels in patients with cardiovascular risk factor. J Atheroscler Thromb, 2009; 16: 371-379
14. Sakane K, Miyoshi T, Doi M, Hirohata S, Kaji Y, Kamikawa S, Ogawa H, Hatanaka K, Kitawaki T, Kusachi S, Yamamoto K: Association of new arterial stiffness parameter, the cardio-ankle vascular index, with left ventricular diastolic function. J Atheroscler Thromb, 2008; 15: 261-268
15. Masugata H, Senda S, Goda F, Yamagami A, Okuyama H, Kohno T, Hosomi N, Yukiiri K, Noma T, Kiyomoto H, Murao K, Nishiyama A, Kohno M: Tissue Doppler echocardiography for predicting arterial stiffness assessed by cardio-ankle vascular index. Tohoku J Exp Med, 2009; 217: 139-146
16. van den Hurk K, Alssema M, Kamp O, Henry RM, Stehouwer CD, Diamant M, Boomsma F, Heine RJ, Nijpels G, Paulus WJ, Dekker JM: Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study. Eur J Heart Fail, 2010; 12: 958-965
17. Wallerson DC, Devereux RB: Reproducibility of echocar- diographic left ventricular measurements. Hypertension, 1987; 9: 6-18
18. Teichholz LE, Kreulen T, Herman MV, Gorlin R: Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol, 1976; 37: 7-11
19. Nishimura RA, Appleton CP: "Diastology": beyond E and A. J Am Coll Cardiol, 1996; 27: 372-374
20. Nishimura RA, Tajik AJ: Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol,1997; 30: 8-18
21. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA: Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol, 1997; 30: 1527-1533
22. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ: Clinical utility of Doppler-echocardiography and tissue Dopplerimaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation, 2000; 102: 1788-1794.
23. Sakuragi S, Okawa K, Iwasaki J, Tokunaga N, Kakishita M, Ohe T: Aortic stiffness is an independent determinant of B-type natriuretic peptide in patients with coronary artery disease. Cardiology, 2007; 107: 140-146
24. Park KH, Park WJ, Kim MK, Jung JH, Choi S, Cho JR, Kim HS, Lee N, Cho GY: Noninvasive brachial-ankle pulse wave velocity in hypertensive patients with left ventricular hypertrophy. Am J Hypertens, 2010; 23: 269-274.
25. Tomiyama H, Yamashina A: CAVI vs. pressure and stiffness gradients in the arterial tree. Hypertens Res, 2010; 33: 380
26. Shirai K, Song M, Suzuki J, Kurosu T, Oyama T, Nagayama D, Miyashita Y, Yamamura S, Takahashi M: Contra- dictory effects of β1and α1-aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)--CAVI independent of blood pressure. J Atheroscler Thromb, 2011; 18: 49-55
27. Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M, Kurihara N, Takeda T: Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med, 1995; 98: 257-265
28. Struthers AD: Diastolic dysfunction and ANP/BNP levels. Eur Heart J, 1996; 17: 1617-1618
29. Gardin JM, Arnold AM, Polak J, Jackson S, Smith V, Gottdiener J: Usefulness of aortic root dimension in persons > or = 65 years of age in predicting heart failure, stroke, cardiovascular mortality, all-cause mortality and acute myocardial infarction (from the Cardiovascular Health Study). Am J Cardiol, 2006; 97: 270-275
30. Cipolli JA, Souza FA, Ferreira-Sae MC, Pio-Magalhães JA, Figueiredo ES, Vidotti VG, Matos-Souza JR, Franchini KG, Nadruz W Jr: Sex-specific hemodynamic and nonhemodynamic determinants of aortic root size in hypertensive subjects with left ventricular hypertrophy. Hypertens Res, 2009; 32: 956-961
31. Cuspidi C, Meani S, Fusi V, Valerio C, Sala C, Zanchetti A: Prevalence and correlates of aortic root dilatation in patients with essential hypertension: relationship with cardiac and extracardiac target organ damage. J Hypertens, 2006; 24: 573-580
32. Cuspidi C, Meani S, Valerio C, Esposito A, Sala C, Maisaidi M, Zanchetti A, Mancia G: Ambulatory blood pres sure, target organ damage and aortic root size in nevertreated essential hypertensive patients. J Hum Hypertens, 2007; 21: 531-538
33. Nielsen OW, Cowburn PJ, Sajadieh A, Morton JJ, Dargie H, McDonagh T: Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care. Eur J Heart Fail, 2007; 9: 1178-1185
34. Shapiro BP, Lam CS, Patel JB, Mohammed SF, Kruger M, Meyer DM, Linke WA, Redfield MM: Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model. Hypertension, 2007; 50: 503-511
35. Haendchen RV, Povzhitkov M, Meerbaum S, Maurer G, Corday E: Evaluation of changes in left ventricular end- diastolic pressure by left atrial two-dimensional echocardiography. Am Heart J, 1982; 104: 740-745
36. Tomiyama H, Yoshida M, Yamada J, Matsumoto C, Odaira M, Shiina K, Yamashina A: Arterial-cardiac destiffening following long-term antihypertensive treatment. Am J Hypertens, 2011; 24: 1080-1086